Agilon Health (NYSE:AGL) Trading Down 8% – What’s Next?

by · The Markets Daily

Agilon Health, Inc. (NYSE:AGL – Get Free Report) was down 8% on Thursday . The stock traded as low as $78.88 and last traded at $77.7950. 51,105 shares were traded during mid-day trading, a decline of 85% from the average session volume of 335,643 shares. The stock had previously closed at $84.56.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on AGL shares. Benchmark reiterated a “buy” rating and set a $140.00 target price (up from $95.00) on shares of Agilon Health in a report on Thursday, August 6th. Wells Fargo & Company restated an “overweight” rating and issued a $146.00 price target (up from $141.00) on shares of Agilon Health in a report on Tuesday, August 11th. Royal Bank Of Canada set a $125.00 price objective on shares of Agilon Health in a research report on Tuesday, September 15th. Citigroup upgraded shares of Agilon Health from a “sell” rating to a “neutral” rating and lifted their price objective for the company from $105.00 to $115.00 in a research note on Monday, August 10th. Finally, Sanford C. Bernstein raised shares of Agilon Health from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $86.00 to $125.00 in a research report on Tuesday, September 15th. Six investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Agilon Health has a consensus rating of “Hold” and an average target price of $102.25.

Read Our Latest Research Report on AGL

Agilon Health Stock Performance

The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08. The stock has a 50-day moving average price of $95.62 and a 200-day moving average price of $73.67. The firm has a market capitalization of $1.23 billion, a PE ratio of -5.16 and a beta of 3.02.

Agilon Health (NYSE:AGL – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.45 billion. On average, research analysts expect that Agilon Health, Inc. will post -2.9 EPS for the current fiscal year.

Institutional Trading of Agilon Health

A number of hedge funds have recently made changes to their positions in AGL. State Street Corp acquired a new stake in Agilon Health in the second quarter valued at $30,024,000. North Peak Capital Management LLC increased its position in shares of Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after purchasing an additional 3,715,460 shares during the last quarter. Rubicon Founders LLC bought a new stake in shares of Agilon Health in the 2nd quarter worth about $11,290,448. Bank of New York Mellon Corp raised its stake in shares of Agilon Health by 9.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company’s stock valued at $3,787,000 after purchasing an additional 3,074 shares in the last quarter. Finally, UBS Group AG raised its stake in shares of Agilon Health by 250.7% in the 4th quarter. UBS Group AG now owns 3,395,366 shares of the company’s stock valued at $2,339,000 after purchasing an additional 2,427,136 shares in the last quarter.

Agilon Health Company Profile

(Get Free Report)

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.

Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations.

Read More